Back to TWO SIGMA ADVISERS, LP TWO SIGMA ADVISERS, LP

RETARETA
11 quarters

Position history for TWO SIGMA ADVISERS, LPTWO SIGMA ADVISERS, LP's holdings in REATA PHARMACEUTICALS INC

TWO SIGMA ADVISERS, LP previously held 0 shares of RETA (REATA PHARMACEUTICALS INC), worth $0 as of 2023-Q3.

Final Value

$0

Final Shares

0

Total Value Change

-$270,000

Total Shares Change

-3,156

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2023-Q3
Latest
Exited
0
-100.0%
$00.0%
0
2023-Q2
Decreased
7,200
-79.5%
$734,1120.0%
0
2023-Q1
Decreased
35,200
-29.9%
$3.2M0.0%
0
2022-Q4
Increased
50,200
+100.8%
$1.9M0.0%
42
2022-Q3
New
25,000
-
$628,0000.0%
34
2020-Q4
Exited
0
-100.0%
$00.0%
0
2020-Q3
Decreased
51,989
-14.9%
$5.1M0.0%
0
2020-Q2
Increased
61,089
+871.4%
$9.5M0.0%
45
2020-Q1
New
6,289
-
$908,0000.0%
34
2019-Q2
Exited
0
-100.0%
$00.0%
0
2019-Q1
New
3,156
-
$270,0000.0%
32

Other major holders of RETA: BNP PARIBAS FINANCIAL MARKETS, Invesco Ltd., FRANKLIN RESOURCES INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used